Natural Beauty Bio-Technology Limited (NBBTF) Fair Value & Analysis
Consumer Defensive · US · Market cap $102M
Fair value as of: Jun 26, 2026
Analysis
Natural Beauty Bio-Technology Limited (NBBTF) currently trades at $0.0610, while our model-based Fair Value estimate is $0.0299 — implying the stock looks roughly 51.0% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Natural Beauty Bio-Technology Limited, an investment holding company, provides skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, beauty, aroma-therapeutic, and make-up products, as well as health supplements under the Natural Beauty brand. The company also offers skin treatments, beauty and spa services, medical cosmetology services, and skin care consulting and beauty training services, as well as beauty apparatus. In addition, its spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, the company engages in the wholesale of skin care and beauty products. Natural Beauty Bio-Technology Limited was founded in 1976 and is based in Causeway Bay, Hong Kong.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Natural Beauty Bio-Technology Limited (NBBTF) undervalued?
What is the fair value of NBBTF?
What is the quality score of NBBTF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.